SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1470Thursday March 29, 8:30 am Eastern Time Press Release SOURCE: Genta IncorporatedPL Wilson-3/29/2001
1469Looks like the full article of the UMich/UCLA article is available. Here is theJim Oravetz-3/29/2001
1468Wednesday March 28, 8:31 am Eastern Time Press Release SOURCE: Genta IncorporatePL Wilson-3/28/2001
1467New Data Reaffirm Genta's Molecular Target as Critical Factor For Enhancing PL Wilson-3/27/2001
1466Monday March 26, 2001 08:34 AM Company Press Release SOURCE:Genta Incorporated John William Anderson-3/26/2001
1465Genta Presents Clinical Update at International Investigator Meetings for Lead SJohn William Anderson-3/15/2001
1464GNTA Reiterated (Strong Buy) Needham & Co. February 9, 2001 Stock Rating ReiPL Wilson-3/11/2001
1463Wednesday March 7, 2001 09:01 AM Company Press Release SOURCE:Genta IncorporateJohn William Anderson-3/7/2001
1462Another Phase 3 trial: Lymphocytic Leukemia Wednesday February 28, 2001 10:20 John William Anderson-2/28/2001
1461Genta Launches Phase 3 Randomized Trial With Genasense(TM) in Multiple Myeloma bob zagorin-2/13/2001
1460Genta Announces Fourth Quarter and Year-end 2000 Results and Highlights BERKELEbob zagorin-2/8/2001
1459Genta Announces Election of Raymond P. Warrell, Jr. as Chairman of the Board BEbob zagorin-2/1/2001
1458Genta Announces Licensing of Antisense Technology to Atugen AG BERKELEY HEIGHTSbob zagorin-1/29/2001
1457reiterated strong buy on GNTA Needham & Co Actions Contains information pertbob zagorin-1/22/2001
1456Genta Begins Two New Genasense Trials In Leukemia Dow Jones Newswires BERKELEY Jim Oravetz-1/19/2001
1455MSN Money Central. "Strong Buy" on GNTA by Zacks Investment Research. PL Wilson-1/8/2001
1454Genta Signs Genasense(TM) Manufacturing and Supply Agreement With Avecia BERKELbob zagorin-12/21/2000
1453Genta Licenses New Platform Technology from National Institutes of Health BERKEbob zagorin-12/21/2000
1452One more fascinating piece of the onco puzzle: Monday December 18, 2000 05:00 PJohn William Anderson-12/20/2000
1451Genta Statement Regarding FDA SessionOn 'Special Exception Use' of Oncolbob zagorin-12/14/2000
1450Inhibition Of Prostate Cancer Growth Reported Using Genta Incorporated's (bob zagorin-12/13/2000
1449Inhibition of Prostate Cancer Growth Reported Using Genta'sAnti-Androgen Combob zagorin-12/13/2000
1448Coverage initiated on Genta, biz.yahoo.comPL Wilson-12/11/2000
1447Option News-Pacific Exchange to Trade Seven New Options PR NEWSWIRE - December 0PL Wilson-12/5/2000
1446Investigators Report Clinical Activity of Genta'sLead Antisense Drug in Acutbob zagorin-12/4/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News